Economic Evaluation of Anticitokines Adalimumab, Etanercept and Infliximab for Treatment of Rheumatoid Arthritis in Paraná State, Brazil [Avaliação Econômica das Anticitocinas Adalimumabe, Etanercepte e Infliximabe No Tratamento da Artrite Reumatoide No Estado do Paraná]
AuthID
P-00S-3TT
P-00S-3TT